about
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kDoes growth hormone cause cancer?[Growth hormone treatment inTurner syndrome: data and reflections].Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression.Gene regulation by growth hormone.Obesity alters gene expression for GH/IGF-I axis in mouse mammary fat pads: differential role of cortistatin and somatostatin.Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.The insulin-like growth factor system: towards clinical applications.Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifeneDairy product consumption and the risk of breast cancer.Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancerPrenatal modulation of breast density and breast stem cells by insulin-like growth factor-1.Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.The contribution of growth hormone to mammary neoplasiaAssociation between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males.A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer.Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.Motherhood after breast cancer: searching for la dolce vita.Antitumor and biological investigation of doubly cyclometalated ruthenium(II) organometallics derived from benzimidazolyl derivatives.Insulin-like growth factor-1 and childhood cancer risk.Mammary stem cell number as a determinate of breast cancer risk.Altered mammary gland development in male rats exposed to genistein and methoxychlor.Polymorphisms in the CRK gene and their association with breast cancer risk.PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells.Role of the growth hormone–IGF-1 axis in cancer
P2860
Q24806371-03127673-B356-43FF-8BD4-CAD1C8D55923Q28293263-56C9C358-4382-4AD8-AC2D-057D32944F9BQ33370093-A681E264-EAC0-4961-8B16-49670F8FF3EEQ33729654-0D0B1F87-0EE5-467F-A547-38AD6B479C47Q33780197-E0186D9B-CB39-4255-B110-F63A9396D620Q34182483-79D33E7A-4230-4E4B-8832-F724F463A1C4Q34526408-C8D7F06F-51E0-4E3E-80E9-A61CF195148AQ34574197-2D91F665-89CF-4265-9ADD-32355024DDA3Q35217246-F29B2560-BCFA-49E4-A02B-22D7E89B9A2EQ35749326-58D02615-E671-49A1-AAB6-CB23B5864DA9Q35819252-E5DE0057-5018-4EE6-8B9E-7AACDD852335Q35933230-66FA6118-B2B0-4A04-B138-F0DBB596745BQ36351148-1C866435-AB27-4AB5-B236-CDF16E118804Q36393112-9DCB103B-3449-4B87-A6A6-84A8528ECEF4Q36581469-B45F43F2-2017-4E6F-950A-06A6CE1750C2Q36796406-6E1DDE1B-CC30-4F74-B904-6B50C583E6F8Q36796684-955E7E68-E5AE-4A12-948D-0D174A867979Q37078157-292EE43B-E096-4CA0-9B0F-445D9999BBA8Q37209924-F3AB8E03-3C1F-4684-98D7-A56F07F6E47FQ37212940-7B92B642-657F-4566-8597-FEB4E93F78DAQ37441195-D31A9D81-4F85-4719-A03B-99CFE762ECA1Q37579225-F94A9E30-296D-4C2F-B1C6-FD9DE3D8232CQ37845835-B2CDE33E-E1AA-4F24-ABA8-601E4F8A5042Q38786564-5DEAC7CE-4654-428E-9829-17BBB15B7A43Q41888993-213B5910-5DBE-438B-A3B6-B61B800C7B35Q42964152-4EABE40E-5BBF-4479-B853-E66FC457088EQ46917255-9DA2D741-77C0-4CC8-B139-D9858FEC7CCFQ47132537-1D79B4AA-DC1C-4718-9C61-1438EFE142EFQ48179406-7EC61A0B-13B9-40D7-A54E-76035C40782CQ57252658-D7870617-EF6B-45BA-A4AD-C620E70E191B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The GH-IGF-I axis and breast cancer.
@ast
The GH-IGF-I axis and breast cancer.
@en
type
label
The GH-IGF-I axis and breast cancer.
@ast
The GH-IGF-I axis and breast cancer.
@en
prefLabel
The GH-IGF-I axis and breast cancer.
@ast
The GH-IGF-I axis and breast cancer.
@en
P1476
The GH-IGF-I axis and breast cancer
@en
P2093
Christiana Laban
Paul J Jenkins
P356
10.1016/S1043-2760(02)00003-6
P577
2003-01-01T00:00:00Z